Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs
about
Bronchial Artery Angiogenesis Drives Lung Tumor Growth.Effects of retinoic acid-inducible gene-I-like receptors activations and ionizing radiation cotreatment on cytotoxicity against human non-small cell lung cancer in vitro.Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment.Using a Classifier Fusion Strategy to Identify Anti-angiogenic Peptides
P2860
Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@ast
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@en
type
label
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@ast
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@en
prefLabel
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@ast
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@en
P2093
P2860
P356
P1433
P1476
Anti-angiogenic efficacy of 5' ...... and RIG-I activation in NSCLCs
@en
P2093
P2860
P304
29664-29674
P356
10.18632/ONCOTARGET.4869
P407
P577
2015-08-27T00:00:00Z